Cargando…
An Update on Anti-thrombotic Therapy Following Transcatheter Aortic Valve Implantation: Expert Cardiologist Opinion from a UK and Ireland Delphi Group
Transcatheter aortic valve implantation (TAVI) is an effective and established treatment for symptomatic aortic stenosis. However, there is a lack of consensus concerning the need for peri- and post-procedural anti-thrombotic medication. Contemporary guidelines recommend that anti-thrombotic therapy...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311398/ https://www.ncbi.nlm.nih.gov/pubmed/37398870 http://dx.doi.org/10.15420/icr.2022.11 |
_version_ | 1785066731940610048 |
---|---|
author | Zaman, Azfar Prendergast, Bernard Hildick-Smith, David Blackman, Daniel Anderson, Richard Spence, Mark S Mylotte, Darren Smith, David Wilding, Ben Chapman, Chris Atkins, Kirsty Pollock, Kevin G Qureshi, Ayesha C Banning, Adrian |
author_facet | Zaman, Azfar Prendergast, Bernard Hildick-Smith, David Blackman, Daniel Anderson, Richard Spence, Mark S Mylotte, Darren Smith, David Wilding, Ben Chapman, Chris Atkins, Kirsty Pollock, Kevin G Qureshi, Ayesha C Banning, Adrian |
author_sort | Zaman, Azfar |
collection | PubMed |
description | Transcatheter aortic valve implantation (TAVI) is an effective and established treatment for symptomatic aortic stenosis. However, there is a lack of consensus concerning the need for peri- and post-procedural anti-thrombotic medication. Contemporary guidelines recommend that anti-thrombotic therapy is balanced against a patient’s bleeding risk following TAVI, but do not fully consider the evolving evidence base. The purpose of the Delphi panel recommendations presented here is to provide a consensus elicited from a panel of experts who regularly prescribe anti-thrombotic therapy post-TAVI. The goal was to address evidence gaps across four key topics: anti-thrombotic therapy (anti-platelet and/or anti-coagulant) in TAVI patients in sinus rhythm; anti-thrombotic therapy in TAVI patients with AF; direct oral anti-coagulants versus vitamin K antagonists; and the need for UK/Ireland specific guidance. This consensus statement aims to inform clinical decision-making by providing a concise, evidence-based summary of best practice for prescribing anti-thrombotic therapies following TAVI and highlights areas where further research is needed. |
format | Online Article Text |
id | pubmed-10311398 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Radcliffe Cardiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-103113982023-07-01 An Update on Anti-thrombotic Therapy Following Transcatheter Aortic Valve Implantation: Expert Cardiologist Opinion from a UK and Ireland Delphi Group Zaman, Azfar Prendergast, Bernard Hildick-Smith, David Blackman, Daniel Anderson, Richard Spence, Mark S Mylotte, Darren Smith, David Wilding, Ben Chapman, Chris Atkins, Kirsty Pollock, Kevin G Qureshi, Ayesha C Banning, Adrian Interv Cardiol Structural Transcatheter aortic valve implantation (TAVI) is an effective and established treatment for symptomatic aortic stenosis. However, there is a lack of consensus concerning the need for peri- and post-procedural anti-thrombotic medication. Contemporary guidelines recommend that anti-thrombotic therapy is balanced against a patient’s bleeding risk following TAVI, but do not fully consider the evolving evidence base. The purpose of the Delphi panel recommendations presented here is to provide a consensus elicited from a panel of experts who regularly prescribe anti-thrombotic therapy post-TAVI. The goal was to address evidence gaps across four key topics: anti-thrombotic therapy (anti-platelet and/or anti-coagulant) in TAVI patients in sinus rhythm; anti-thrombotic therapy in TAVI patients with AF; direct oral anti-coagulants versus vitamin K antagonists; and the need for UK/Ireland specific guidance. This consensus statement aims to inform clinical decision-making by providing a concise, evidence-based summary of best practice for prescribing anti-thrombotic therapies following TAVI and highlights areas where further research is needed. Radcliffe Cardiology 2023-04-10 /pmc/articles/PMC10311398/ /pubmed/37398870 http://dx.doi.org/10.15420/icr.2022.11 Text en Copyright © 2023, Radcliffe Cardiology https://creativecommons.org/licenses/by-nc/4.0/This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly. |
spellingShingle | Structural Zaman, Azfar Prendergast, Bernard Hildick-Smith, David Blackman, Daniel Anderson, Richard Spence, Mark S Mylotte, Darren Smith, David Wilding, Ben Chapman, Chris Atkins, Kirsty Pollock, Kevin G Qureshi, Ayesha C Banning, Adrian An Update on Anti-thrombotic Therapy Following Transcatheter Aortic Valve Implantation: Expert Cardiologist Opinion from a UK and Ireland Delphi Group |
title | An Update on Anti-thrombotic Therapy Following Transcatheter Aortic Valve Implantation: Expert Cardiologist Opinion from a UK and Ireland Delphi Group |
title_full | An Update on Anti-thrombotic Therapy Following Transcatheter Aortic Valve Implantation: Expert Cardiologist Opinion from a UK and Ireland Delphi Group |
title_fullStr | An Update on Anti-thrombotic Therapy Following Transcatheter Aortic Valve Implantation: Expert Cardiologist Opinion from a UK and Ireland Delphi Group |
title_full_unstemmed | An Update on Anti-thrombotic Therapy Following Transcatheter Aortic Valve Implantation: Expert Cardiologist Opinion from a UK and Ireland Delphi Group |
title_short | An Update on Anti-thrombotic Therapy Following Transcatheter Aortic Valve Implantation: Expert Cardiologist Opinion from a UK and Ireland Delphi Group |
title_sort | update on anti-thrombotic therapy following transcatheter aortic valve implantation: expert cardiologist opinion from a uk and ireland delphi group |
topic | Structural |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311398/ https://www.ncbi.nlm.nih.gov/pubmed/37398870 http://dx.doi.org/10.15420/icr.2022.11 |
work_keys_str_mv | AT zamanazfar anupdateonantithrombotictherapyfollowingtranscatheteraorticvalveimplantationexpertcardiologistopinionfromaukandirelanddelphigroup AT prendergastbernard anupdateonantithrombotictherapyfollowingtranscatheteraorticvalveimplantationexpertcardiologistopinionfromaukandirelanddelphigroup AT hildicksmithdavid anupdateonantithrombotictherapyfollowingtranscatheteraorticvalveimplantationexpertcardiologistopinionfromaukandirelanddelphigroup AT blackmandaniel anupdateonantithrombotictherapyfollowingtranscatheteraorticvalveimplantationexpertcardiologistopinionfromaukandirelanddelphigroup AT andersonrichard anupdateonantithrombotictherapyfollowingtranscatheteraorticvalveimplantationexpertcardiologistopinionfromaukandirelanddelphigroup AT spencemarks anupdateonantithrombotictherapyfollowingtranscatheteraorticvalveimplantationexpertcardiologistopinionfromaukandirelanddelphigroup AT mylottedarren anupdateonantithrombotictherapyfollowingtranscatheteraorticvalveimplantationexpertcardiologistopinionfromaukandirelanddelphigroup AT smithdavid anupdateonantithrombotictherapyfollowingtranscatheteraorticvalveimplantationexpertcardiologistopinionfromaukandirelanddelphigroup AT wildingben anupdateonantithrombotictherapyfollowingtranscatheteraorticvalveimplantationexpertcardiologistopinionfromaukandirelanddelphigroup AT chapmanchris anupdateonantithrombotictherapyfollowingtranscatheteraorticvalveimplantationexpertcardiologistopinionfromaukandirelanddelphigroup AT atkinskirsty anupdateonantithrombotictherapyfollowingtranscatheteraorticvalveimplantationexpertcardiologistopinionfromaukandirelanddelphigroup AT pollockkeving anupdateonantithrombotictherapyfollowingtranscatheteraorticvalveimplantationexpertcardiologistopinionfromaukandirelanddelphigroup AT qureshiayeshac anupdateonantithrombotictherapyfollowingtranscatheteraorticvalveimplantationexpertcardiologistopinionfromaukandirelanddelphigroup AT banningadrian anupdateonantithrombotictherapyfollowingtranscatheteraorticvalveimplantationexpertcardiologistopinionfromaukandirelanddelphigroup AT zamanazfar updateonantithrombotictherapyfollowingtranscatheteraorticvalveimplantationexpertcardiologistopinionfromaukandirelanddelphigroup AT prendergastbernard updateonantithrombotictherapyfollowingtranscatheteraorticvalveimplantationexpertcardiologistopinionfromaukandirelanddelphigroup AT hildicksmithdavid updateonantithrombotictherapyfollowingtranscatheteraorticvalveimplantationexpertcardiologistopinionfromaukandirelanddelphigroup AT blackmandaniel updateonantithrombotictherapyfollowingtranscatheteraorticvalveimplantationexpertcardiologistopinionfromaukandirelanddelphigroup AT andersonrichard updateonantithrombotictherapyfollowingtranscatheteraorticvalveimplantationexpertcardiologistopinionfromaukandirelanddelphigroup AT spencemarks updateonantithrombotictherapyfollowingtranscatheteraorticvalveimplantationexpertcardiologistopinionfromaukandirelanddelphigroup AT mylottedarren updateonantithrombotictherapyfollowingtranscatheteraorticvalveimplantationexpertcardiologistopinionfromaukandirelanddelphigroup AT smithdavid updateonantithrombotictherapyfollowingtranscatheteraorticvalveimplantationexpertcardiologistopinionfromaukandirelanddelphigroup AT wildingben updateonantithrombotictherapyfollowingtranscatheteraorticvalveimplantationexpertcardiologistopinionfromaukandirelanddelphigroup AT chapmanchris updateonantithrombotictherapyfollowingtranscatheteraorticvalveimplantationexpertcardiologistopinionfromaukandirelanddelphigroup AT atkinskirsty updateonantithrombotictherapyfollowingtranscatheteraorticvalveimplantationexpertcardiologistopinionfromaukandirelanddelphigroup AT pollockkeving updateonantithrombotictherapyfollowingtranscatheteraorticvalveimplantationexpertcardiologistopinionfromaukandirelanddelphigroup AT qureshiayeshac updateonantithrombotictherapyfollowingtranscatheteraorticvalveimplantationexpertcardiologistopinionfromaukandirelanddelphigroup AT banningadrian updateonantithrombotictherapyfollowingtranscatheteraorticvalveimplantationexpertcardiologistopinionfromaukandirelanddelphigroup |